VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MNOVMediciNova, Inc.
$1.29$63M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMNOVRevenue History

MNOV logoMediciNova, Inc. (MNOV) Revenue History

Annual and quarterly revenue from 2003 to present

TTM Revenue$597K▲ +$187K vs FY2025
YoY Growth—
Q1 2026$187K+23.2% QoQ
Revenue CAGR
3Y—
→
5Y—
→
10Y—
Best Fiscal Year$263.9M (2007)
Best Quarter$66.7M (Q2 2007)
Revenue per Share$0.01
Revenue per Employee$46K

MNOV Revenue Over Time (2003–2025)

MNOV Revenue Growth History

3 of 8 years with positive growth
Annual Revenue Growth · Each cell = one fiscal year
2003—
2004—
2005+64.0%
2006-67.2%
2007+99900.0%
2008-100.0%
2009—
2010—
2011—
2012—
2013+648.0%
2014-100.0%
2015—
2016—
2017—
2018—
2019—
2020—
2021—
2022-100.0%
2023—
2024-100.0%
2025—
FY2003 revenue growth
N/A
FY2004 revenue growth
N/A
FY2005 revenue growth
+64.0%
FY2006 revenue growth
-67.2%
FY2007 revenue growth
+99900.0%
FY2008 revenue growth
-100.0%
FY2009 revenue growth
N/A
FY2010 revenue growth
N/A
FY2011 revenue growth
N/A
FY2012 revenue growth
N/A
FY2013 revenue growth
+648.0%
FY2014 revenue growth
-100.0%
FY2015 revenue growth
N/A
FY2016 revenue growth
N/A
FY2017 revenue growth
N/A
FY2018 revenue growth
N/A
FY2019 revenue growth
N/A
FY2020 revenue growth
N/A
FY2021 revenue growth
N/A
FY2022 revenue growth
-100.0%
FY2023 revenue growth
N/A
FY2024 revenue growth
-100.0%
FY2025 revenue growth
N/A
DeclineStrong growth
Best: +99900.0% (FY2007)Worst: -100.0% (FY2008)
Recent Quarterly Revenue & YoY Growth
QuarterRevenueYoY
Q1 2026$187K—
Q4 2025$152K—
Q3 2025$123K—
Q2 2025$135K—
Q1 2025$0—
Q4 2024$0—
Q3 2024$0-100.0%
Q2 2024$0—
Seasonal Revenue Pattern (fiscal quarters)
Q1
25%
Q2
28%
Q3
23%
Q4
25%

Multi-year avg. share of annual revenue by fiscal quarter

MNOV Revenue Analysis (2003–2025)

Current Revenue & Growth

As of June 28, 2026, MediciNova, Inc. (MNOV) generated trailing twelve-month (TTM) revenue of $596,641. The most recent quarter (Q1 2026) recorded $186,984 in revenue, up 23.2% sequentially.

Historical Growth Trajectory

MNOV's historical revenue data shows various trends over time. MediciNova, Inc.'s highest annual revenue of $263.9 million was recorded in 2007.

Peer Comparison

Compared to Healthcare sector peers — including SIGA (-22.1% YoY), and NRXP. Compare MNOV vs SIGA →

MNOV Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
MNOV logoMNOVCurrent$596,641---3242.5%
SIGA logoSIGA$95M-22.1%-5.4%25.1%
NRXP logoNRXP$1M---1324.4%
Best in groupLowest in group

MNOV Historical Revenue Data (2003–2025)

1–15 of 23 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$410K-$31K7.6%$-13,283,000-3242.5%
2024$0-100.0%$0-$-12,675,331-
2023$1.0M-$1.0M100.0%$-9,900,265-990.0%
2022$0-100.0%$0-$-14,628,649-
2021$4.0M-$4.0M100.0%$-10,215,812-253.0%
2020$0-$0-$-14,178,323-
2019$0-$-23,944-$-14,031,077-
2018$0-$-25,881-$-15,586,826-
2017$0-$-28,098-$-13,027,093-
2016$0-$-14,127-$-10,881,834-
2015$0-$-26,704-$-8,822,386-
2014$0-100.0%$0-$-9,223,011-
2013$6.0M+648.0%$6.0M100.0%$-4,020,540-67.0%
2012$803K-$803K100.0%$-10,945,356-1363.8%
2011$0-$0-$-16,108,434-
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

23+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MNOV — Frequently Asked Questions

Quick answers to the most common questions about buying MNOV stock.

Is MNOV's revenue growth accelerating or slowing?

MNOV TTM revenue: $596641.00. YoY growth: N/A. 5-year CAGR: N/A.

What is MNOV's revenue history from 2003 to 2026?

MediciNova, Inc. (MNOV) revenue history spans 2003 to 2026. TTM revenue as of 2026 is $596641.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.

What is MNOV's long-term revenue growth rate (CAGR)?

MediciNova, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for MNOV.

Why does MNOV's quarterly revenue fluctuate?

MNOV quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. MediciNova, Inc.'s revenue data from 2003 to 2026 shows full historical quarterly detail on this page.

How is MNOV's revenue distributed by segment?

MNOV reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.

How does MNOV's revenue compare to industry peers?

MediciNova, Inc. (MNOV) with TTM revenue of $596641.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.